Cargando…
Management of the Hospitalized Transplant Patient
Significant hyperglycemia is commonly observed immediately after solid organ and bone marrow transplant as well as with subsequent hospitalizations. Surgery and procedures are well known to cause pain and stress leading to secretion of cytokines and other hormones known to aggravate insulin action....
Autores principales: | Boerner, Brian, Shivaswamy, Vijay, Goldner, Whitney, Larsen, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342522/ https://www.ncbi.nlm.nih.gov/pubmed/25721247 http://dx.doi.org/10.1007/s11892-015-0585-6 |
Ejemplares similares
-
PSUN188 Evaluating Response to GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Managed at a Veterans Affairs Hospital
por: Davis, Clifton, et al.
Publicado: (2022) -
Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation
por: Boerner, Brian P., et al.
Publicado: (2014) -
Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear
por: Yeh, Tiffany, et al.
Publicado: (2021) -
SAT-121 Immediate Dysglycemia After Pancreatic Resection: Prevalence and Risk Factors
por: Enke, Thomas, et al.
Publicado: (2019) -
Physician-community pharmacist collaborative care in diabetes management: a pilot study
por: Mouhtadi, Bouchra Bakr, et al.
Publicado: (2018)